Intuitive Surgical stock slips as 2026 growth outlook cools — what to watch before Monday
Intuitive Surgical shares fell 0.35% to $523.99 Friday after the company forecast 13%-15% procedure growth for 2026 and warned tariffs could cut margins by 1.2% of revenue. Fourth-quarter revenue rose 19% to $2.87 billion, with da Vinci 5 placements up but Ion placements down. The FDA cleared da Vinci 5 for select cardiac procedures this week.